Shanghai Huaota Biopharmaceutical Co., Ltd.

This early-stage trial tests a new drug called HB0043 in 15 adults with moderate to severe hidradenitis suppurativa, a painful skin condition. The drug targets two proteins involved in inflammation to reduce flare-ups. The main goal is to check safety and see if it helps control …

This early-stage study tests whether the experimental drug HB0056 is safe and tolerable in healthy adults. About 46 volunteers aged 18 to 55 will receive a single dose and be monitored for side effects. The goal is to gather safety data, not to treat any disease.